Prelude Therapeutics (PRLD) Cash from Operations (QoQ) (2020 - 2026)
Prelude Therapeutics (PRLD) Cash from Operations (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Prelude Therapeutics | 324.30 Mn | 179.71 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -193.80% |
| Dec 31, 2025 | 220.95% |
| Sep 30, 2025 | 26.69% |
| Jun 30, 2025 | 23.83% |
| Mar 31, 2025 | -65.02% |
| Dec 31, 2024 | 24.00% |
| Sep 30, 2024 | -18.38% |
| Jun 30, 2024 | 27.47% |
| Mar 31, 2024 | -34.83% |
| Dec 31, 2023 | 8.20% |
| Sep 30, 2023 | 7.17% |
| Jun 30, 2023 | 8.18% |
| Mar 31, 2023 | -31.43% |
| Dec 31, 2022 | -12.17% |
| Sep 30, 2022 | -10.67% |
| Jun 30, 2022 | 15.65% |
| Mar 31, 2022 | 14.81% |
| Dec 31, 2021 | -18.04% |
| Sep 30, 2021 | -9.35% |
| Jun 30, 2021 | -23.35% |